Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures

Asian Journal of Andrology

Volumn 14, Issue 3, 2012, Pages 499-504

  Larré, Stéphane ^a,b   Camparo, Philippe ^b,c   Comperat, Eva ^b,d   Boulbés, Delphine ^b   Haddoum, Mohammed ^e   Baulande, Sylvain ^f   Soularue, Pascal ^f   Costa, Pierre ^g   Cussenot, Olivier ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SORBONNE UNIVERSITÉ   (France)

^c University of Paris Descartes   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Laboratoire Solvay Pharma   (France)

^f PartnerChip   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

Author keywords

benign prostatic hyperplasia; organotypic culture; PNT2; primary culture; Pygeum africanum; transcriptome; WPMY

Indexed keywords

PYGEUM AFRICANUM EXTRACT; TRANSCRIPTOME;

ADULT; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MALE; MYOFIBROBLAST; OXIDATIVE STRESS; PROSTATE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PYGEUM; SERUM; UPREGULATION;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MYOFIBROBLASTS; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATE; PROSTATIC HYPERPLASIA; PYGEUM; SERUM;

EID: 84860872806     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.132     Document Type: Article

References (25)

1. Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: A systematic review and quantitative meta-Analysis. Am J Med 2000; 109: 654-664.
2. Buck AC. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol 2004; 172: 1792-1799. (Pubitemid 39363057)
3. Levin RM, Das AK. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 2000; 28: 201-209. (Pubitemid 30435681)
4. Boulbès D, Soustelle L, Costa P, Haddoum M, Bali JP et al. Pygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblasts. BJU Int 2006; 98: 1106-1113. (Pubitemid 44536467)
5. Quiles MT, Arbos MA, Fraga A, de Torres IM, Reventos J et al. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH). Prostate 2010; 70: 1044-1053.
6. Shenouda NS, Sakla MS, Newton LG, Besch-Williford C, Greenberg NM et al. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine 2007; 31: 72-81. (Pubitemid 350194198)
7. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004; 46: 547-554. (Pubitemid 39345720)
8. Roell D, Baniahmad A. The natural compounds atraric acid and N-butylbenzenesulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth. Mol Cell Endocrinol 2011; 332: 1-8.
9. Papini S, Rosellini A, de Matteis A, Campani D, Selli C et al. Establishment of an organotypic in vitro culture system and its relevance to the characterization of human prostate epithelial cancer cells and their stromal interactions. Pathol Res Pract 2007; 203: 209-216. (Pubitemid 46605959)
10. Yablonsky F, Nicolas V, Riffaud JP, Bellamy F. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. J Urol 1997; 157: 2381-2387. (Pubitemid 27208726)
11. Ropiquet F, Berthon P, Villette JM, Le Brun G, Maitland NJ et al. Constitutive expression of FGF2/bFGF in non-Tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype. Int J Cancer 1997; 72: 543-547. (Pubitemid 27325886)
12. Descazeaud A, Rubin MA, Hofer M, Setlur S, Nikolaief N et al. BPH gene expression profile associated to prostate gland volume. Diagn Mol Pathol 2008; 17: 207-213.
13. Verlaan DJ, Davenport WJ, Stefan H, Sure U, Siegel AM et al. Cerebral cavernous malformations: Mutations in Krit1. Neurology 2002; 58: 853-857. (Pubitemid 34242058)
14. Abraham RT. The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways. DNA Repair (Amst) 2004; 3: 919-925. (Pubitemid 38997933)
15. Shintani M, Tada M, Kobayashi T, Kajiho H, Kontani K et al. Characterization of Rab45/RASEF containing EF-hand domain and a coiled-coil motif as a selfassociating GTPase. Biochem Biophys Res Commun 2007; 357: 661-667. (Pubitemid 46653830)
16. Jonsson G, Bendahl PO, Sandberg T, Kurbasic A, Staaf J et al. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst 2005; 97: 1377-1382. (Pubitemid 41487805)
17. Muller-Tidow C, Diederichs S, Thomas M, Serve H. Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 2004; 45(Suppl 2): S145-50. (Pubitemid 39488184)
18. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E et al. Humoral immunity to human breast cancer: Antigen definition and quantitative analysis of mRNA expression. Cancer Immun 2001; 1: 4.
19. Takikawa M, Akiyama Y, Maruyama K, Suzuki A, Liu F et al. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis. Oncol Rep 2006; 16: 705-711.
20. Cui H, Darmanin S, Natsuisaka M, Kondo T, Asaka M et al. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. Cancer Res 2007; 67: 3345-3355. (Pubitemid 46724874)
21. Lolkema MP, Mans DA, Snijckers CM, van Noort M, van BeestMet al. The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2. FEBS Lett 2007; 581: 4571-4576. (Pubitemid 47418779)
22. Iida R, Yasuda T, Tsubota E, Takatsuka H, Matsuki T et al. Human Mpv17-like protein is localized in peroxisomes and regulates expression of antioxidant enzymes. Biochem Biophys Res Commun 2006; 344: 948-954.
23. Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 2003; 22: 2443-2452. (Pubitemid 36604983)
24. Kassen A, Berges R, Senge T. Effect of beta-sitosterol on transforming growth factorbeta-1 expression and translocation protein kinase C alpha in human prostate stromal cells in vitro. Eur Urol 2000; 37: 735-741. (Pubitemid 30255794)
25. Fromont G, Chene L, Latil A, Bieche I, Vidaud M et al. Molecular profiling of benign prostatic hyperplasia using a large scale real-Time reverse transcriptase-polymerase chain reaction approach. J Urol 2004; 172: 1382-1385.(Pubitemid 39249725)